IMU 0.00% 5.2¢ imugene limited

IMU - The Value Proposition, page-166

  1. 1,620 Posts.
    lightbulb Created with Sketch. 381
    I guess you are bound to see volatility when the product is still unproven. You can have the best scientists in the world working on a problem but it deosn't guarantee success in science, not by a long shot.

    All we know at this point is that people have had a strong immune response to the vaccine. This is very very promising. When the results start coming through on Her-Vaxx we will know where this stock stands and we will have a much clearer idea of the real world efficacy of B-cell technology.

    As an investor I see the takeover of Mayo as interesting and possibly highly beneficial longer term.

    For the time being EVERYTHING hinges on the results of the Her-Vaxx trial.

    I think our chances are better than average. That is why I'm an investor, but let's not get carried away until we see the results.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.2¢
Change
0.000(0.00%)
Mkt cap ! $378.4M
Open High Low Value Volume
5.2¢ 5.3¢ 5.1¢ $362.6K 7.026M

Buyers (Bids)

No. Vol. Price($)
38 3723479 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 894256 26
View Market Depth
Last trade - 12.56pm 23/08/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.